About Medtronic plc
Medtronic plc is a medical device company that develops, manufactures, and sells device-based medical therapies across four business portfolios: Cardiovascular, Medical Surgical, Neuroscience, and Diabetes. Earl Bakken and his brother-in-law Palmer Hermundslie founded the company in 1949 in Minneapolis, Minnesota, as a medical equipment repair business focused on medical electronics. Medtronic first listed its shares on the New York Stock Exchange in 1977 under the ticker MDT, where they continue to trade. The company is now headquartered in Galway, Ireland, and is a component of both the S&P 500 and S&P 100 indices. Its products include cardiac pacemakers, implantable cardiac devices, transcatheter heart valves, spinal and neuromodulation systems, surgical robotics and monitoring equipment, and diabetes technologies such as insulin pumps and continuous glucose monitoring systems. The company operates in the medical devices and healthcare technology sector, covering electromechanical medical equipment, surgical instruments, and related device-based therapies. Medtronic is one of the largest medical device companies in the world by revenue and product breadth.
No recent coverage for this asset.
A sourced map of Medtronic plc's relationships is on the way.
Partners, competitors and related assets, each link independently verified and source-linked before it appears here.
The Crypto Briefing podcast is on the way.
Conversations on Medtronic plc and the wider market, hosted by our team, will appear here once episodes are live.